Veraxa Biotech Holding AG (VRXA) Assets (2024 - 2025)

Veraxa Biotech Holding AG's (VRXA) quarterly Assets came in at $101.1 million in Q4 2025, up 4.5% year-on-year from $96.8 million in Q4 2024, and up 4.5% on a QoQ basis from $96.8 million in Q4 2024.

Veraxa Biotech Holding AG (VRXA) Assets (2024 - 2025) Analysis & Trends

Veraxa Biotech Holding AG (VRXA) has 2 years of Assets data on file, last reported at $101.1 million in Q4 2025.

  • On a quarterly basis, Assets rose 4.5% year-over-year to $101.1 million in Q4 2025; TTM through Dec 2025 was $101.1 million, a 4.5% increase from a year earlier, with the FY2025 full-year figure at $101.1 million, up 4.5% from the prior year.
  • Assets for Q4 2025 stood at $101.1 million, up from $96.8 million in the prior quarter.
  • Over the last five years, Assets for VRXA reached as high as $101.1 million in Q4 2025 and fell as low as $96.8 million in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 101.12 Mn
Dec 31, 2024 96.76 Mn